These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 23894390)
1. Co-expression of Lewis y antigen with human epididymis protein 4 in ovarian epithelial carcinoma. Zhuang H; Gao J; Hu Z; Liu J; Liu D; Lin B PLoS One; 2013; 8(7):e68994. PubMed ID: 23894390 [TBL] [Abstract][Full Text] [Related]
2. The expression of annexin II and Lewis y antigen in ovarian epithelial tumors and the correlation between them. Zhuang H; Tan M; Liu J; Li X; Gao J; Hu Z; Deng L; Zhu L; Lin B Tumour Biol; 2015 Apr; 36(4):2343-9. PubMed ID: 25416440 [TBL] [Abstract][Full Text] [Related]
3. Study on the expression and clinical significances of lewis y antigen and integrin αv, β3 in epithelial ovarian tumors. Wang Y; Liu J; Lin B; Wang C; Li Q; Liu S; Yan L; Zhang S; Iwamori M Int J Mol Sci; 2011; 12(6):3409-21. PubMed ID: 21747684 [TBL] [Abstract][Full Text] [Related]
4. The stimulation of IGF-1R expression by Lewis(y) antigen provides a powerful development mechanism of epithelial ovarian carcinoma. Liu D; Liu J; Wang C; Lin B; Liu Q; Hao Y; Zhang S; Iwamori M Int J Mol Sci; 2011; 12(10):6781-95. PubMed ID: 22072919 [TBL] [Abstract][Full Text] [Related]
5. Expression and correlation of Lewis y antigen and TGF-β1 in ovarian epithelial carcinoma. Wang ST; Liu JJ; Wang CZ; Lin B; Hao YY; Wang YF; Gao S; Qi Y; Zhang SL; Iwamori M Oncol Rep; 2012 Apr; 27(4):1065-71. PubMed ID: 22138668 [TBL] [Abstract][Full Text] [Related]
6. Lewis(y) antigen promotes the progression of epithelial ovarian cancer by stimulating MUC1 expression. Hou R; Jiang L; Liu D; Lin B; Hu Z; Gao J; Zhang D; Zhang S; Iwamori M Int J Mol Med; 2017 Aug; 40(2):293-302. PubMed ID: 28586014 [TBL] [Abstract][Full Text] [Related]
7. Chemoresistance is associated with MUC1 and Lewis y antigen expression in ovarian epithelial cancers. Zhang D; Gao J; Zhu L; Hu Z; Hou R; Liu S; Tan M; Liu J; Lin B Int J Mol Sci; 2013 May; 14(6):11024-33. PubMed ID: 23708102 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of Lewis y antigen promotes human epididymis protein 4-mediated invasion and metastasis of ovarian cancer cells. Zhuang H; Hu Z; Tan M; Zhu L; Liu J; Liu D; Yan L; Lin B Biochimie; 2014 Oct; 105():91-8. PubMed ID: 24998328 [TBL] [Abstract][Full Text] [Related]
9. Human Epididymis Protein 4 and Lewis y Enhance Chemotherapeutic Resistance in Epithelial Ovarian Cancer Through the p38 MAPK Pathway. Gao J; Zhu L; Zhuang H; Lin B Adv Ther; 2022 Jan; 39(1):360-378. PubMed ID: 34739698 [TBL] [Abstract][Full Text] [Related]
10. Human epididymis protein 4 promotes P‑glycoprotein‑mediated chemoresistance in ovarian cancer cells through interactions with Annexin II. Liu Q; Liu DW; Zheng MJ; Deng L; Wang HM; Jin S; Liu JJ; Hao YY; Zhu LC; Lin B Mol Med Rep; 2021 Jul; 24(1):. PubMed ID: 33955501 [TBL] [Abstract][Full Text] [Related]
11. Clinical value of human epididymis protein 4 and the Risk of Ovarian Malignancy Algorithm in differentiating borderline pelvic tumors from epithelial ovarian cancer in early stages. Kotowicz B; Fuksiewicz M; Sobiczewski P; Spiewankiewicz B; Jonska-Gmyrek J; Skrzypczak M; Kowalska M Eur J Obstet Gynecol Reprod Biol; 2015 Nov; 194():141-6. PubMed ID: 26398337 [TBL] [Abstract][Full Text] [Related]
12. Does Human Epididymis Protein 4 (HE4) Have a Role in Prediction of Recurrent Epithelial Ovarian Cancer. Innao P; Pothisuwan M; Pengsa P Asian Pac J Cancer Prev; 2016; 17(9):4483-4486. PubMed ID: 27797265 [TBL] [Abstract][Full Text] [Related]
13. Does risk for ovarian malignancy algorithm excel human epididymis protein 4 and CA125 in predicting epithelial ovarian cancer: a meta-analysis. Li F; Tie R; Chang K; Wang F; Deng S; Lu W; Yu L; Chen M BMC Cancer; 2012 Jun; 12():258. PubMed ID: 22712526 [TBL] [Abstract][Full Text] [Related]
14. Interpretation of single and serial measures of HE4 and CA125 in asymptomatic women at high risk for ovarian cancer. Urban N; Thorpe J; Karlan BY; McIntosh MW; Palomares MR; Daly MB; Paley P; Drescher CW Cancer Epidemiol Biomarkers Prev; 2012 Nov; 21(11):2087-94. PubMed ID: 22962406 [TBL] [Abstract][Full Text] [Related]
15. [Comparison of serum cancer antigen 125, human epididymis protein 4, ROMA, and CPH-I for diagnosis of ovarian cancer in Chinese patients with ovarian mass]. Shipeng G; Yongning C; Yadi Z; Chanyuan LI; Qifan J Nan Fang Yi Ke Da Xue Xue Bao; 2019 Dec; 39(12):1393-1401. PubMed ID: 31907150 [TBL] [Abstract][Full Text] [Related]
16. High expressions of BCL6 and Lewis y antigen are correlated with high tumor burden and poor prognosis in epithelial ovarian cancer. Zhu L; Feng H; Jin S; Tan M; Gao S; Zhuang H; Hu Z; Wang H; Song Z; Lin B Tumour Biol; 2017 Jul; 39(7):1010428317711655. PubMed ID: 28671040 [TBL] [Abstract][Full Text] [Related]
17. Expression of Lewis y antigen and integrin αv, β3 in ovarian cancer and their relationship with chemotherapeutic drug resistance. Gao J; Hu Z; Liu D; Liu J; Liu C; Hou R; Gao S; Zhang D; Zhang S; Lin B J Exp Clin Cancer Res; 2013 Jun; 32(1):36. PubMed ID: 23725446 [TBL] [Abstract][Full Text] [Related]
18. Role of human epididymis protein 4 in chemoresistance and prognosis of epithelial ovarian cancer. Lee S; Choi S; Lee Y; Chung D; Hong S; Park N J Obstet Gynaecol Res; 2017 Jan; 43(1):220-227. PubMed ID: 27862665 [TBL] [Abstract][Full Text] [Related]
19. Co‑expression of Lewis y antigen and CD147 in epithelial ovarian cancer is correlated with malignant progression and poor prognosis. Liu J; Liu Q; Wang Y; Liu M; Qi Y; Gao J; Lin B Int J Mol Med; 2019 Apr; 43(4):1687-1698. PubMed ID: 30816446 [TBL] [Abstract][Full Text] [Related]
20. Significance of HE4 estimation in comparison with CA125 in diagnosis of ovarian cancer and assessment of treatment response. Hamed EO; Ahmed H; Sedeek OB; Mohammed AM; Abd-Alla AA; Abdel Ghaffar HM Diagn Pathol; 2013 Jan; 8():11. PubMed ID: 23343214 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]